$1.60
0.095.96%
Pre-Market: 9:25 AM EDT
15 minutes delayed
Plus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Plus Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.71 | $-0.53 | -34.0 % |
Mar 2024 | 2024-05-15 | $-0.75 | $-1.09 | 31.2 % |
Dec 2023 | 2024-03-05 | $-0.70 | $-1.07 | 34.6 % |
Sep 2023 | 2023-10-31 | $-1.00 | $-1.12 | 10.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $1.28M | $1.67M | -23.4 % |
Mar 2024 | 2024-05-15 | $1.68M | $1.69M | -0.77 % |
Dec 2023 | 2024-03-05 | $1.31M | $1.06M | 23.9 % |
Sep 2023 | 2023-10-31 | $1.24M | $1.29M | -3.88 % |
Plus Therapeutics (PSTV) is scheduled to report earnings on October 29, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.71, which missed the estimate of $-0.53.
The Actual Revenue was $1.3M, which missed the estimate of $1.7M.
Browse earnings estimates, EPS, and revenue on all stocks.